Search Results - "Sánchez‐Blázquez, Pilar"

Refine Results
  1. 1
  2. 2

    Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor by Rodríguez-Muñoz, María, Onetti, Yara, Cortés-Montero, Elsa, Garzón, Javier, Sánchez-Blázquez, Pilar

    Published in Molecular brain (17-09-2018)
    “…Cannabidiol (CBD), the major non-psychotomimetic compound present in the Cannabis sativa plant, exhibits therapeutic potential for various human diseases,…”
    Get full text
    Journal Article
  3. 3

    Chronic Pain Leads to Concomitant Noradrenergic Impairment and Mood Disorders by Alba-Delgado, Cristina, Llorca-Torralba, Meritxell, Horrillo, Igor, Ortega, Jorge E, Mico, Juan Antonio, Sánchez-Blázquez, Pilar, Meana, J. Javier, Berrocoso, Esther

    Published in Biological psychiatry (1969) (2013)
    “…Background Patients suffering chronic pain are at high risk of suffering long-lasting emotional disturbances characterized by persistent low mood and anxiety…”
    Get full text
    Journal Article
  4. 4

    The Mu-Opioid Receptor and the NMDA Receptor Associate in PAG Neurons: Implications in Pain Control by RODRIGUEZ-MUNOZ, María, SANCHEZ-BLAZQUEZ, Pilar, VICENTE-SANCHEZ, Ana, BERROCOSO, Esther, GARZON, Javier

    Published in Neuropsychopharmacology (01-01-2012)
    “…The capacity of opioids to alleviate inflammatory pain is negatively regulated by the glutamate-binding N-methyl-D-aspartate receptor (NMDAR). Increased…”
    Get full text
    Journal Article
  5. 5

    Analgesic antidepressants promote the responsiveness of locus coeruleus neurons to noxious stimulation: Implications for neuropathic pain by Alba-Delgado, Cristina, Mico, Juan Antonio, Sánchez-Blázquez, Pilar, Berrocoso, Esther

    Published in Pain (Amsterdam) (01-07-2012)
    “…The activity of locus coeruleus upon nociceptive stimulation is altered in neuropathic pain conditions, being restored by analgesic antidepressant treatment…”
    Get full text
    Journal Article
  6. 6

    Calmodulin Supports TRPA1 Channel Association with Opioid Receptors and Glutamate NMDA Receptors in the Nervous Tissue by Cortés-Montero, Elsa, Rodríguez-Muñoz, María, Ruiz-Cantero, María Del Carmen, Cobos, Enrique José, Sánchez-Blázquez, Pilar, Garzón-Niño, Javier

    “…Transient receptor potential ankyrin member 1 (TRPA1) belongs to the family of thermo TRP cation channels that detect harmful temperatures, acids and numerous…”
    Get full text
    Journal Article
  7. 7

    Schizophrenia and depression, two poles of endocannabinoid system deregulation by Rodríguez-Muñoz, María, Sánchez-Blázquez, Pilar, Callado, Luis F., Meana, J. Javier, Garzón-Niño, Javier

    Published in Translational psychiatry (18-12-2017)
    “…The activity of certain G protein-coupled receptors (GPCRs) and of glutamate N -Methyl-D-aspartate receptors (NMDARs) is altered in both schizophrenia and…”
    Get full text
    Journal Article
  8. 8

    Ligands Exert Biased Activity to Regulate Sigma 1 Receptor Interactions With Cationic TRPA1, TRPV1, and TRPM8 Channels by Cortés-Montero, Elsa, Sánchez-Blázquez, Pilar, Onetti, Yara, Merlos, Manuel, Garzón, Javier

    Published in Frontiers in pharmacology (12-06-2019)
    “…The sigma 1 receptor (σ1R) and the mu-opioid receptor (MOR) regulate the transient receptor potential (TRP) V1 calcium channel. A series of proteins are…”
    Get full text
    Journal Article
  9. 9

    Mu-opioid receptors transiently activate the Akt-nNOS pathway to produce sustained potentiation of PKC-mediated NMDAR-CaMKII signaling by Sánchez-Blázquez, Pilar, Rodríguez-Muñoz, María, Garzón, Javier

    Published in PloS one (23-06-2010)
    “…In periaqueductal grey (PAG) matter, cross-talk between the Mu-opioid receptor (MOR) and the glutamate N-methyl-D-Aspartate receptor (NMDAR)-CaMKII pathway…”
    Get full text
    Journal Article
  10. 10

    The Sigma 2 receptor promotes and the Sigma 1 receptor inhibits mu-opioid receptor-mediated antinociception by Sánchez-Blázquez, Pilar, Cortés-Montero, Elsa, Rodríguez-Muñoz, María, Merlos, Manuel, Garzón-Niño, Javier

    Published in Molecular brain (11-11-2020)
    “…The Sigma-1 receptor (σ1R) has emerged as an interesting pharmacological target because it inhibits analgesia mediated by mu-opioid receptors (MOR), and also…”
    Get full text
    Journal Article
  11. 11

    The function of alpha-2-adrenoceptors in the rat locus coeruleus is preserved in the chronic constriction injury model of neuropathic pain by Alba-Delgado, Cristina, Borges, Gisela, Sánchez-Blázquez, Pilar, Ortega, Jorge E., Horrillo, Igor, Mico, Juan A., Meana, J. Javier, Neto, Fani, Berrocoso, Esther

    Published in Psychopharmacologia (01-05-2012)
    “…Rationale Peripheral neuropathic pain is a chronic condition that may produce plastic changes in several brain regions. The noradrenergic locus coeruleus (LC)…”
    Get full text
    Journal Article
  12. 12

    SUMO-SIM interactions regulate the activity of RGSZ2 proteins by Garzón, Javier, Rodríguez-Muñoz, María, Vicente-Sánchez, Ana, García-López, María Ángeles, Martínez-Murillo, Ricardo, Fischer, Thierry, Sánchez-Blázquez, Pilar

    Published in PloS one (06-12-2011)
    “…The RGSZ2 gene, a regulator of G protein signaling, has been implicated in cognition, Alzheimer's disease, panic disorder, schizophrenia and several human…”
    Get full text
    Journal Article
  13. 13

    Gz Mediates the Long-Lasting Desensitization of Brain CB1 Receptors and is Essential for Cross-Tolerance with Morphine by Garzón, Javier, de la Torre-Madrid, Elena, Rodríguez-Muñoz, María, Vicente-Sánchez, Ana, Sánchez-Blázquez, Pilar

    Published in Molecular pain (10-03-2009)
    “…Background Although the systemic administration of cannabinoids produces antinociception, their chronic use leads to analgesic tolerance as well as…”
    Get full text
    Journal Article
  14. 14

    Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction by Rodríguez-Muñoz, María, Sánchez-Blázquez, Pilar, Merlos, Manuel, Garzón-Niño, Javier

    Published in Oncotarget (23-08-2016)
    “…Glutamate is probably the most important excitatory neurotransmitter in the brain. The glutamate N-methyl-D-aspartate receptor (NMDAR) is a calcium-gated…”
    Get full text
    Journal Article
  15. 15

    The Sigma-1 Receptor Antagonist, S1RA, Reduces Stroke Damage, Ameliorates Post-Stroke Neurological Deficits and Suppresses the Overexpression of MMP-9 by Sánchez-Blázquez, Pilar, Pozo-Rodrigálvarez, Andrea, Merlos, Manuel, Garzón, Javier

    Published in Molecular neurobiology (01-06-2018)
    “…The glutamate N-methyl-D-aspartate receptor (NMDAR) plays an essential role in the excitotoxic neural damage that follows ischaemic stroke. Because the sigma-1…”
    Get full text
    Journal Article
  16. 16

    Morphine Induces Endocytosis of Neuronal μ-opioid Receptors Through the Sustained Transfer of Gα Subunits to RGSZ2 Proteins by Rodríguez-Muñoz, María, de la Torre-Madrid, Elena, Sánchez-Blázquez, Pilar, Garzón, Javier

    Published in Molecular pain (17-07-2007)
    “…Background: In general, opioids that induce the recycling of μ-opioid receptors (MORs) promote little desensitization, although morphine is one exception to…”
    Get full text
    Journal Article
  17. 17

    Cannabinoid receptors couple to NMDA receptors to reduce the production of NO and the mobilization of zinc induced by glutamate by Sánchez-Blázquez, Pilar, Rodríguez-Muñoz, María, Vicente-Sánchez, Ana, Garzón, Javier

    Published in Antioxidants & redox signaling (20-11-2013)
    “…Overactivation of glutamate N-methyl-D-aspartate receptor (NMDAR) increases the cytosolic concentrations of calcium and zinc, which significantly contributes…”
    Get more information
    Journal Article
  18. 18

    α N -Acetyl β-Endorphin Is an Endogenous Ligand of σ1Rs That Regulates Mu-Opioid Receptor Signaling by Exchanging G Proteins for σ2Rs in σ1R Oligomers by Garzón-Niño, Javier, Cortés-Montero, Elsa, Rodríguez-Muñoz, María, Sánchez-Blázquez, Pilar

    “…The opioid peptide β-endorphin coexists in the pituitary and brain in its -acetylated form, which does not bind to opioid receptors. We now report that these…”
    Get full text
    Journal Article
  19. 19

    The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia by Sánchez-Blázquez, Pilar, Rodríguez-Muñoz, María, Garzón, Javier

    Published in Frontiers in pharmacology (02-01-2014)
    “…The endocannabinoid system is widespread throughout the central nervous system and its type 1 receptor (CB1) plays a crucial role in preventing the…”
    Get full text
    Journal Article
  20. 20

    RGS9 proteins facilitate acute tolerance to mu-opioid effects by Garzón, Javier, Rodríguez-Díaz, Marta, López-Fando, Almudena, Sánchez-Blázquez, Pilar

    Published in The European journal of neuroscience (01-02-2001)
    “…This paper reports that regulators of G‐protein signalling (RGS) proteins modulate the timing and amplitude of opioid signals by a push–pull mechanism. This is…”
    Get full text
    Journal Article